Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Eradication Therapy for H. pylori with Ilaprazole
NCT02648659Phase 4Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Mar 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of ilaprazole in Helicobacter pylori infection and peptic ulcer disease (PUD) (3 arms), sponsored by Kyungpook National University Hospital. Primary endpoint: Eradication rate after tailored therapy. Started Mar 2016; status: completed.
02
Drugs
ilaprazole
03
Conditions
Helicobacter pylori infectionpeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT02648659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648659.